@article{56896fee14ff445c975d707c7920d74c,
title = "Effectiveness of Tirofiban, Eptifibatide, and Abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)",
abstract = "The TEAM pilot study underscores the importance of adequate platelet inhibition (>90\% PI) in high-risk PCI, and demonstrates that attaining >90\% PI is possible in most patients by adding a half-bolus of any GP IIb/IIIa inhibitor, with no increase in major/minor bleeding similar periprocedural myocardial necrosis, and 30-day MACE with all 3 GP IIb/IIIa inhibitors.",
author = "Kini, \{Annapoorna S.\} and Merwin Richard and Javed Suleman and Nohelia Perez and Paul Lee and Fisher, \{Edward A.\} and Mazullah Kamran and Marmur, \{Jonathan D.\} and Sharma, \{Samin K.\}",
note = "Funding Information: This report was supported by unrestricted grants from Merck Inc., West Point, Pennsylvania; and COR Therapeutics Inc., South San Francisco, California. ",
year = "2002",
month = sep,
day = "1",
doi = "10.1016/S0002-9149(02)02528-6",
language = "English",
volume = "90",
pages = "526--529",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",
}